Showing 24 out of 36 results
Herbert Smith Freehills advises sole sponsor on Shanghai Bio-heart's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人律师为百心安香港IPO提供法律服务
Leading international law firm Herbert Smith Freehills has advised Huatai Financial Holdings (Hong Kong) Limited as the sole sponsor of biopharmaceutical …
Kewei adds corporate senior consultant Angela Zhao to China joint operation with Herbert Smith Freehills 科伟律师事务所迎来公司事务资深顾问赵秋丹 加入与史密夫斐尔联营办公室
Kewei Law Firm has appointed Angela Zhao as a senior consultant in Shanghai, further expanding its corporate expertise in the firm's joint operation with …
Climate change: succeed in a net-zero future
The risks associated with climate change go way beyond the purely environmental.In our climate change briefing we consider at a high level the political, …
Herbert Smith Freehills advises sponsors on Abbisko’s HK$1.754 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为和誉开曼17.54亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley and J.P. Morgan as joint sponsors of biopharmaceutical company Abbisko Cayman …
Herbert Smith Freehills advises sponsors on Acotec Scientific’s HK$1.529 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为先瑞达医疗15.29亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley and CICC as joint sponsors of medical device manufacturer Acotec Scientific …
Herbert Smith Freehills advises on Shanghai HeartCare Medical's HK$1.13 billion Hong Kong IPO 史密夫斐尔律师事务所为心玮医疗11.3亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised neuro-interventional medical device manufacturer Shanghai HeartCare Medial Technology …
Herbert Smith Freehills advises sponsors on Brii Biosciences’ HK$2.483 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为腾盛博药24.83亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley and UBS as joint sponsors of biopharmaceutical company Brii Biosciences …
Herbert Smith Freehills advises sponsors on CARsgen Therapeutics’ HK$3.1 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为科济药业31亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and UBS as joint sponsors of biopharmaceutical company CARsgen Therapeutics …
Nanda Lau to lead Herbert Smith Freehills’ China corporate practice 刘依兰将领导史密夫斐尔中国公司事务
Shanghai partner Nanda Lau has been named Herbert Smith Freehills’ new head of the firm’s China corporate practice, effective 1 May 2021.She replaces …
Asia Pacific M&A Review 2021
Our eighth annual review of Asia's deal scene assesses the outlook for big-ticket M&A after a turbulent but eventful yearChange is the only constant …
Herbert Smith Freehills advises on Gland Pharma’s US$872 million India IPO / 史密夫斐尔律师事务所为Gland Pharma 8.72亿美元印度IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised the book running lead managers on the global offering and listing of Gland Pharma Limited on …
Herbert Smith Freehills advises sponsors on Antengene’s HK$2.6 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为德琪医药26亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and JP Morgan as joint sponsors of biopharmaceutical company Antengene …
Showing 24 out of 36 results
View more